Skip to content
Ichilov Medical Center
Oncology

Treatment of T-Cell Lymphoblastic Lymphoma in Israel

Oncologists and hematologists at the Ichilov clinic have an expert reputation and extensive experience in treating T-cell lymphoblastic lymphoma in Israel. They utilize the most effective methods and innovative approaches with proven efficacy. Therapy at the medical center is based on individually tailored methods and regimens, based on the genetic profile of the tumor and the overall condition of the patient. Ichilov actively uses and develops the latest targeted therapeutic agents and immunotherapy methods, taking into account the molecular and immune mechanisms of disease development.

>80%
of patients choose an online consultation with an Israeli expert even before arriving at the clinic
>30%
of patients received innovative treatment unavailable in local clinics
2384
patients have utilized comprehensive medical services

Treatment of T-Cell Lymphoblastic Lymphoma in IsraelThe medical center is equipped with the latest diagnostic and treatment equipment, including PET-CT, digital 3D imaging, and the latest generation linear accelerators. Treatment is organized in close collaboration among various medical specialists: oncologists, hematologists, histopathologists, radiologists, and others who develop a multi-component action plan for each patient.

The clinic pays great attention not only to treatment but also to the quality of life of patients, providing qualified psychological and organizational support, as well as comprehensive rehabilitation programs.

About the Disease

T-cell lymphoblastic lymphoma is a rare and aggressive type of non-Hodgkin lymphoma that affects T-lymphocytes. It is a subtype of a broader group of acute lymphoblastic leukemias/lymphomas (ALL/LBL) of T-cell phenotype. The disease is caused by mutations in T-lymphocytes, leading to their uncontrolled growth and division. Mutated cells can accumulate in lymph nodes, blood, and other organs.

In the WHO classification, acute T-cell lymphoblastic lymphoma/leukemia is divided into several subtypes based on morphology, immunophenotype, cytogenetic, and molecular characteristics.

The exact causes of most cases of T-cell lymphomas are unknown. Risk factors are believed to include genetic predisposition, immune disorders, and prior exposure to certain chemicals or radiation therapy. Certain viruses, such as HIV, are also known to increase the risk of developing lymphoma.

Signs of the disease may include:

  • rapid enlargement of lymph nodes,
  • weight loss,
  • fever,
  • excessive fatigue,
  • night sweats,
  • abdominal pain due to enlarged spleen or liver,
  • infectious complications due to suppression of normal immune function.

A question about your case?

Send your records — an Ichilov physician will reply within 1–2 days, free of charge.

Treatment Methods for the Disease

The Ichilov clinic conducts intensive, multi-step treatment of T-cell lymphoblastic lymphoma. The main goal of therapy is to achieve remission, prevent relapses, and optimize prognosis.

Chemotherapy

The primary treatment method uses drugs that suppress the activity of microorganisms and tumor cells. Therapy is conducted in four stages:

  1. induction chemotherapy, aimed at rapidly achieving remission by intensively destroying malignant cells. The first and most aggressive stage;
  2. consolidation phase. Conducted after achieving remission to consolidate the result and destroy residual cancer cells that have proven resistant to drugs;
  3. intensification, including a set of less intensive drugs than the previous ones with various schemes and dosages;
  4. maintenance phase. Low-intensity chemotherapy to maintain remission and prevent relapse.

Radiation Therapy

Modern radiotherapy is based on the use of high-energy radiation to destroy pathological cells. For patients with T-cell lymphoblastic lymphoma, this type of treatment is rarely used in a mono variant but is included in a comprehensive treatment strategy. Radiation therapy is used for disease control and local impact.

The Ichilov medical center is equipped with the most modern linear accelerators, TrueBeam and Lunac. This advanced radiotherapy equipment allows for precise targeting and modulated power with minimal impact on healthy tissues.

Targeted Therapy and Immunotherapy

New treatment approaches focus on targeted effects on the body. Unlike traditional chemotherapy drugs that act systemically on the entire body, targeted therapy is based on drugs aimed at specific protein characteristics and mechanisms of T-lymphoblastic cell transformation. Immunotherapy is a broad, innovative direction built on medications that activate the internal forces of the immune system to fight the disease.

Stem Cell Transplantation

In some cases, after induction of remission, stem cell transplantation may be required to restore bone marrow. Surgeons at Ichilov perform two types of operations:

  • autologous, where stem cells for transplantation are taken from the patient's own blood or bone marrow;
  • allogeneic, where healthy stem cells are obtained from a donor genetically compatible with the patient.

  • Stem Cell Treatment
  • Radiation Therapy
  • Chemotherapy

Diagnostic Methods for the Disease

First Day

The doctor collects a complete medical history, including family history of diseases, and conducts a physical examination, paying special attention to enlarged lymph nodes, liver, and spleen.

Second Day

  • Blood laboratory tests
  • Immunophenotyping
  • Lymph node biopsy or other affected tissues and histological examination
  • Cytogenetic studies and molecular diagnostics
  • Imaging studies: CT, MRI, PET
  • Aspiration and trepanobiopsy of bone marrow to confirm invasion by lymphoblasts and assess cellular composition.

Third Day

Diagnosis and treatment of T-cell lymphoblastic lymphoma require an integrated and multidisciplinary approach. At Ichilov, various specialists participate in the diagnostic process: hematologist, oncologist, radiologist, and others. After interpreting the research results, an optimal treatment plan is collaboratively developed, taking into account the specific features of the disease's progression in the individual patient.

  • Biopsy
  • Computed Tomography
  • Magnetic Resonance Imaging (MRI)
  • Diagnostics — PET CT
  • Biopsy and histological studies
  • Cytology

How Much Does Treatment Cost

The treatment plan at the Ichilov clinic is developed individually for each patient, considering all aspects of the disease and overall health status. The cost depends on the specialists involved, the number and complexity of diagnostic and therapeutic procedures.

You can ask any questions by phone, through online chat, or a special form on the website. An experienced medical coordinator will explain how the price of the treatment program is formed, what it includes, and how much individual procedures cost. You will learn about the technical capabilities of the medical center, where to find information about departments and doctors, ratings, and reviews.

Advantages of Treatment in Israel

  1. High qualification of medical staff
  2. Personalized approach
  3. Innovative treatment strategies and advanced technologies
  4. Multidisciplinary teams of doctors
  5. High level of care and support, rehabilitation programs

Israel is a country with high-quality service and positive medical statistics for the treatment of hematological diseases of the lymphatic system. You can order a consultation with a leading specialist in this field today. Through a video call via Zoom or Skype, the doctor will provide a preliminary assessment based on the research results you have and recommendations for further actions.

Get a treatment plan

Attach your discharge notes and imaging — Ichilov physicians will review and propose an optimal plan.

    By submitting this form you agree to the privacy policy.

    • Hospital representative office — contract and payment go directly to the clinic
    • Free and non-binding · coordinator replies within 30 minutes during working hours
    • Hospital quote within 1–2 business days

    Request a callback

    A coordinator will call back shortly and answer your questions.

    By submitting this form you agree to the privacy policy.

    • Hospital representative office — contract and payment go directly to the clinic
    • Free and non-binding · coordinator replies within 30 minutes during working hours
    • Hospital quote within 1–2 business days